Fenebrutinib Maintains Low Disease Activity in Relapsing Multiple Sclerosis: Results from the FENopta Trial Open-label Extension (P8-1.005)

Authors

Michal Dufek (ORCID: https://orcid.org/0000-0003-3773-4510)
Jiwon Oh (ORCID: https://orcid.org/0000-0001-5519-6088)
Jack Ratchford
Alexandra Goodyear
David Clayton (ORCID: https://orcid.org/0000-0002-3850-8200)
Ying-Fang Chen
Hrvoje Budinčević (ORCID: https://orcid.org/0000-0002-0184-8949)
Mario Habek (ORCID: https://orcid.org/0000-0002-3360-1748)
Amit Bar‐Or (ORCID: https://orcid.org/0000-0001-7179-0335)
Jelena Drulović (ORCID: https://orcid.org/0000-0002-4516-3458)
Malgorzata Sierzega
Maresa Caunt

Institutions

Roche (Switzerland) (CH)
University Hospital Centre Zagreb (HR)
California University of Pennsylvania (US)
Klinička bolnica "Sveti Duh" (HR)
University Hospital Brno (CZ)
St. Anne's University Hospital Brno (CZ)

Publication Details

Journal: Neurology
Published: 2025-04-07
DOI: https://doi.org/10.1212/wnl.0000000000209016
Citations: 1
Primary Topic: Lung Cancer Treatments and Mutations
Type: article
Field-Weighted Citation Impact: 1.52

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Fenebrutinib Maintains Low Disease Activity in Relapsing Multiple Sclerosis: Results from the FENopta Trial Open-label Extension (P8-1.005)

Michal Dufek, Jiwon Oh, Jack Ratchford, Alexandra Goodyear et al.

Apr 7, 2025

1 citations

Neurology

Lung Cancer Treatments and Mutations

1.52

article

Fenebrutinib Maintains Low Disease Activity in Relapsing Multiple Sclerosis: Results from the FENopta Trial Open-label Extension (P8-1.005)

Michal Dufek, Jiwon Oh, Jack Ratchford, Alexandra Goodyear, David Clayton, Ying-Fang Chen, Hrvoje Budinčević, Mario Habek, Amit Bar‐Or, Jelena Drulović, Malgorzata Sierzega, Maresa Caunt

April 7, 2025article en

1 citations

Abstract

No abstract available for this paper.

NeurologyVol. 104(7_Supplement_1)

Roche (Switzerland) (CH), University Hospital Centre Zagreb (HR), California University of Pennsylvania (US), Klinička bolnica "Sveti Duh" (HR), University Hospital Brno (CZ), St. Anne's University Hospital Brno (CZ)

Good health and well-being

Openalex Percentile: Top 20%

Lung Cancer Treatments and Mutations

1.52

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.